CDC | Uso de vacina de mRNA contra COVID-19 após relatos de miocardite entre vacinados – “A continuação do uso das vacinas de mRNA contra a COVID-19 em todos os grupos etários recomendados vai prevenir a morbidade e a mortalidade por COVID-19 em números que excedem muito o número de casos esperados de miocardite.”

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 – Centers for Disease Control and Prevention

Comentário no Twitter

In a new @CDCMMWR, the Advisory Committee on Immunization Practices recommends everyone 12 & older get a #COVID19 vaccine. The benefits of vaccination in preventing illness & death outweigh the rare risk of heart inflammation after vaccination. More: https://t.co/iPjbhU5jeV. pic.twitter.com/IggrZ4DX7L

— CDC (@CDCgov) July 6, 2021